CAS 73573-87-2
:Formoterol
Description:
Formoterol is a long-acting beta-2 adrenergic agonist primarily used in the management of asthma and chronic obstructive pulmonary disease (COPD). It functions by relaxing bronchial smooth muscle, leading to bronchodilation and improved airflow. Formoterol is characterized by its rapid onset of action, typically within minutes, and its prolonged duration of effect, lasting up to 12 hours or more. The substance is often administered via inhalation, either as a standalone medication or in combination with corticosteroids. Chemically, formoterol is a racemic mixture, with both R- and S-enantiomers contributing to its pharmacological activity. It is soluble in organic solvents but has limited solubility in water, which influences its formulation in inhalation devices. The compound is generally well-tolerated, though potential side effects may include tremors, palpitations, and headache. As with other beta-agonists, it is essential to use formoterol as prescribed to avoid potential adverse effects associated with overuse.
Formula:C19H24N2O4
InChI:InChI=1/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)/t13-,19+/s2
InChI key:InChIKey=BPZSYCZIITTYBL-KINVLMLONA-N
SMILES:[C@H](CN[C@H](CC1=CC=C(OC)C=C1)C)(O)C2=CC(NC=O)=C(O)C=C2
Synonyms:- rel-N-[2-Hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide
- Formamide, N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, (R*,R*)-(±)-
- Formamide, N-[2-hydroxy-5-[(1R)-1-hydroxy-2-[[(1R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, rel-
- Formoterol
- Eformoterol
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 3 products.
Formoterol
CAS:Controlled Product<p>Beta2-agonist</p>Formula:C19H24N2O4Purity:Min. 95%Color and Shape:White PowderMolecular weight:344.4 g/mol
